Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of bioequivalence of two enrofloxacin formulations after intramuscular administration in goats

  • Received : 2012.11.21
  • Accepted : 2013.02.22
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was planned to evaluate the bioequivalence of two commercial formulations of enrofloxacin, which have been marketed as 10% injectable solution after intramuscular administration at a single dose of 2.5 mg/kg body weight to 12 clinically healthy goats The study was carried out on the basis of crossover design. The two formulations were: Baytril as a reference product and Spectrama Vet as a test product. The plasma concentrations of enrofloxacin were measured by high performance liquid chromatography (HPLC) with UV detector. The pharmacokinetics of that data was performed using non-compartmental analysis. The maximum plasma concentration ($C_{max}$), time to reach peak concentration ($T_{max}$), area under concentration-time curve (AUC), elimination half-life ($t_{0.5el}$) were 1.14 and $1.05{\mu}g/mL$, 0.79 and 0.83 h, 5.70 and $5.79{\mu}g.h/mL$, 5.19 and 5.39 h for Baytril and Spectrama Vet, respectively. The 90% confidence interval for the mean ratio of $T_{max}$, $C_{max}$ and AUC were 94.72-116.2, 87.88-97.16 and 86.44-118.72%, respectively. These values falls within the European Medicines Agency bioequivalence acceptance range of 80-125% for both $T_{max}$ and AUC and between 75-133% for $C_{max}$. In conclusion, Spectrama-Vet is bioequivalent to Baytril and both products can be used as interchangeable drug in veterinary medicine practice.

Keywords

References

  1. Abo El-Sooud K. Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats. Pharmacol Res 2003, 48, 389-395. https://doi.org/10.1016/S1043-6618(03)00179-8
  2. Ahangar AH, Srivastava AK. Pharmacokinetics of enrofloxacin in febrile crossbred bovine calves. Indian J Pharmacol 2000, 32, 305-308.
  3. Alvinerie M, Lacoste E, Sutra JF, Chartier C. Some pharmacokinetic parameters of eprinomectin in goats following pour-on administration. Vet Res Commun 1999, 23, 449-455. https://doi.org/10.1023/A:1006373609314
  4. Anadon A, Martinez-Larranaga MR, Diaz MJ, Fernandez-Cruz ML, Martinez MA, Frejo MT, Martinez M, Iturbe J, Tafur M. Pharmacokinetic variables and tissue residues of enrofloxcin and ciprofloxacin in healthy pigs. Am J Vet Res 1999, 60, 1377-1382.
  5. Bimazubute M, Cambier C, Baert K, Vanbelle S, Chiap P, Albert A, Delporte JP, Gustin P. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther 2010, 33, 183-188. https://doi.org/10.1111/j.1365-2885.2009.01123.x
  6. Broome RL, Brooks DL, Babish JG, Copeland DD, Conzelman GM. Pharmacokinetic properties of enrofloxacin in rabbits. Am J Vet Res 1991, 52, 1835-1841.
  7. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther 1996, 19, 1-14. https://doi.org/10.1111/j.1365-2885.1996.tb00001.x
  8. Chen ML, Shah V, Patnaik R, Adams W, Hussain A, Conner D, Mehta M, Alinowski H, Lazor J, Huang SM, Hare D, Lesko L, Sporn D, Williams R. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res 2001, 18, 1645-1650. https://doi.org/10.1023/A:1013319408893
  9. Davis JL, Foster DM, Papich MG. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. J Vet Pharmacol Ther 2007, 30, 564-571. https://doi.org/10.1111/j.1365-2885.2007.00914.x
  10. Dorfman M, Barsanti J, Budsberg SC. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis. Am J Vet Res 1995, 56, 386-390.
  11. Drusano GL, Johnson DE, Rosen M, Standiford HC. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother 1993, 37, 483-490. https://doi.org/10.1128/AAC.37.3.483
  12. Dudley MN. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. Am J Med 1991, 91, 45S-50S.
  13. Elmas M, Tras B, Kaya S, Bas AL, Yazar E, Yarsan, E. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats. Can J Vet Res 2001, 65, 64-67.
  14. Elmas M, Uney K, Yazar E, Karabacak A, Tra B. Pharmacokinetics of enrofloxacin following intravenous and intramuscular administration in Angora rabbits. Res Vet Sci 2007, 82, 242-245. https://doi.org/10.1016/j.rvsc.2006.06.008
  15. Elsheikh HA, Taha AA, Khalafallah AI, Osman IA. Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay. Res Vet Sci 2002, 73, 125-129. https://doi.org/10.1016/S0034-5288(02)00020-6
  16. Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993, 37, 1073-1081. https://doi.org/10.1128/AAC.37.5.1073
  17. Gibaldi M, Perrier D. Non Compartmental Analysis Based on Statistical Moment Theory Pharmacokinetics, 2nd edn, pp 409-417. Marcel Dekker, New York, 1982.
  18. Giguere S, Sweeney RW, Belanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996, 57, 1025-1030.
  19. Haddad NS, Pedersoli WM, Ravis WR, Fazeli MH, Carson RL. Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. Am J Vet Res 1985, 46, 2004-2007.
  20. Haritova A, Lashev L, Pashov D. Pharmacokinetics of enrofloxacin in lactating sheep. Res Vet Sci 2003, 74, 241-245. https://doi.org/10.1016/S0034-5288(03)00003-1
  21. Kaartinen L, Pyorala S, Moilanen M, Raisanen S. Pharmacokinetics of enrofloxacin in new-born and oneweek-old calves. J Vet Pharmacol Ther 1997, 20, 479-482. https://doi.org/10.1046/j.1365-2885.1997.00100.x
  22. Kaartinen L, Salonen M, Alli L, Pyorala S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther 1995, 18, 357-362. https://doi.org/10.1111/j.1365-2885.1995.tb00604.x
  23. Kim MS, Lim JH, Park BK, Hwang YH, Yun HI. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus). J Vet Pharmacol Ther 2006, 29, 397-402. https://doi.org/10.1111/j.1365-2885.2006.00783.x
  24. Kung K, Riond JL, Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of Baytril in dogs. J Vet Pharmacol Ther 1993, 16, 462-468. https://doi.org/10.1111/j.1365-2885.1993.tb00212.x
  25. Langston VC, Sedrich S, Boothe DM. Disposition of single dose oral enrofloxacin in the horse. J Vet Pharmacol Ther 1996, 19, 316-319. https://doi.org/10.1111/j.1365-2885.1996.tb00057.x
  26. Lewbart G, Vaden S, Deen J, Manaugh C, Whitt D, Doi A, Smith T, Flammer K. Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brechypomum) after intramuscular, oral and bath administration. J Vet Pharmacol Ther 1997, 20, 124-128. https://doi.org/10.1046/j.1365-2885.1997.00814.x
  27. Lode H, Borner K, Koeppe P. Pharmacodynamics of fluoroquinolones. Clin Infect Dis 1998, 27, 33-39. https://doi.org/10.1086/514623
  28. Madaras-Kelly KJ, Ostergaard BE, Hovde LB, Rotschafer JC. Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model. Antimicrob Agents Chemother 1996, 40, 627-632.
  29. Nielsen P, Gyrd-Hansen N. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacol Toxicol 1997, 80, 246-250. https://doi.org/10.1111/j.1600-0773.1997.tb01967.x
  30. Ovando HG, Gorla N, Luders C, Poloni G, Errecalde C, Prieto G, Puelles I. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in chickens. J Vet Pharmacol Ther 19990, 22, 209-212.
  31. Ozdemir N, Yildirim M. Bioequivalence study of two long-acting oxytetracycline formulations in sheep. Vet Res Commun. 2006, 30, 929-934. https://doi.org/10.1007/s11259-006-3235-2
  32. Prescott JF, Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res 1990, 54, 195-197.
  33. Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats. Vet Res Commun 2001, 25, 197-204. https://doi.org/10.1023/A:1006481625615
  34. Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik, JK. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid. Vet J 2002, 163, 85-93. https://doi.org/10.1053/tvjl.2001.0594
  35. Schroder J. Enrofloxacin: a new antimicrobial agent. J S Afr Vet Asso 1989, 60, 122-124.
  36. Toutain PL, Koritz GD. Veterinary drug bioequivalence determination. J Vet Pharmacol Ther 1997, 20, 79-90. https://doi.org/10.1046/j.1365-2885.1997.00047.x
  37. Vancutsem PM, Babish JG, Schwark WS. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 1990, 80, 173-186.
  38. Walker RD. The use of fluoroquinolones for companion animal antimicrobial therapy. Aust Vet J 2000, 78, 84-90. https://doi.org/10.1111/j.1751-0813.2000.tb10528.x
  39. Walker RD, Stein GE, Hauptman JG, McDonald KH. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res 1992, 53, 2315-2319.
  40. Zechiedrich EL, Cozzarelli NR. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli, Genes Dev 1995, 9, 2859-2869. https://doi.org/10.1101/gad.9.22.2859

Cited by

  1. Physicochemical characterization and pharmacokinetics in broiler chickens of a new recrystallized enrofloxacin hydrochloride dihydrate vol.38, pp.2, 2015, https://doi.org/10.1111/jvp.12153
  2. Postparturient disorders and backfat loss in tropical sows associated with parity, farrowing duration and type of antibiotic vol.47, pp.8, 2015, https://doi.org/10.1007/s11250-015-0883-7